Up next
Arizona doctor’s husband spotted for the first time after allegedly leaving 2-year-old daughter in hot car for three hours.
Author
Internewscast
FacebookXRedditPinterest
The US Food and Drug Administration (FDA) has approved the first ever life-saving nasal spray for the treatment of severe allergic reactions. The approval, announced Friday, offers an alternative to the millions of people who until now have had to rely on injections—known to most as EpiPens. The nasal spray, which will be sold under the brand name Neffy, is designed to be used in place of auto-injectable pens filled with epinephrine (aka adrenaline, a hormone that can be used in drug form to treat allergic emergencies). The new drug only requires a single spray into one nostril and is approved for use in adults and children weighing over 66 pounds.
“The approval we received today offers the initial epinephrine option for treating anaphylaxis that does not require an injection,” stated Kelly Stone, MD, PhD, who serves as the associate director of the Division of Pulmonology, Allergy and Critical Care at the FDA. “Anaphylaxis is a severe condition that can be life-threatening, and certain individuals, especially children, might hesitate or refuse treatment because of their fear of injections.”
Anaphylaxis—the life-threatening condition that can occur within seconds of encountering an allergen—may occur in one in 50 Americans, according to the Asthma and Allergy Foundation of America. Stats are hard to come by, however, and some believe the number could be as high as one in 20 Americans. “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of anaphylaxis. As a result, neffy provides an important treatment option and addresses an unmet need,” Dr. Stone said in the statement.
In September 2023, the FDA declined to approve the drug and requested additional testing, despite recommendations from independent experts, according to Reuters. Neffy has been tested in 175 healthy adults without anaphylaxis, due to ethical concerns. The concentration of epinephrine in the blood after administration was comparable to those who received an EpiPen injection instead. Neither the FDA, nor the makers of Neffy, ARS Pharmaceuticals, have announced when the drug will be available for purchase.
This comes as welcome news to anyone who personally deals with life-threatening allergies—or knows or cares for someone who does. And, thanks to its new method of delivery, Neffy may prove less intimidating to use at various life and age stages than traditional needle-injections pens.
FacebookXRedditPinterest
You May Also Like
- Health
A survey indicates that almost 50% of patients are unfamiliar with the term ‘physician associate’ amid NHS efforts to expand their role in providing healthcare.
More than half of patients do not know what a ‘physician associate’…
- Internewscast
- August 19, 2024
- Health
“Beware: These Two Common Food Choices May Contribute to the Increase in Colon Cancer Cases”
Stark new research has warned that one diet choice may play a…
- Internewscast
- August 18, 2024
- Health
Following her husband’s fight against cancer and her unexpected diagnosis of bone disease, Ruth Sunderland, Business Editor, writes a letter to her future self at 70, outlining her plans to maintain good health throughout her later years.
Stumbling into your ‘older self’ is a disconcerting experience. Until it happened…
- Internewscast
- August 18, 2024
- Health
People with bladder issues are forced to deal with painful infections from catheters on their own
Thousands of patients who require a catheter to go to the toilet…
- Internewscast
- August 18, 2024
- Health
The Power of Raw Beetroot: A Nutritionist’s Guide to its Health Benefits and Delicious Ways to Enjoy It
It is one of those vegetables that most people either love or…
- Internewscast
- August 18, 2024
- Health
Gentle Workouts for Embracing Your Body During the Soft Girl Era – Well+Good
For a long time, I was all about hardcore workouts: HIIT, cycling,…
- Internewscast
- August 18, 2024
- Health
Cutting-edge £1.7bn NHS drugs changing lives by altering DNA to treat heart disease, cancer, and blindness.
Drugs that can edit and rewrite DNA are set to banish problems…
- Internewscast
- August 18, 2024
- Health
Nutrition expert advises against dieting for weight loss
The summer seasonis often synonymous with dieting, but health experts are sounding…
- Internewscast
- August 18, 2024
- Health
The Potential Risks of Clapping for NHS During the Pandemic
Applause for the NHS during the pandemic may have been ‘dangerous’, as…
- Internewscast
- August 18, 2024
- Health
Avoid following the peroxide teeth whitening trend to prevent the occurrence of ‘black hairy tongue’ issue.
A dentist has warned against an online trend that claims to whiten…
- Internewscast
- August 18, 2024